Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

16.3%

22 terminated/withdrawn out of 135 trials

Success Rate

82.7%

-3.8% vs industry average

Late-Stage Pipeline

53%

72 trials in Phase 3/4

Results Transparency

57%

60 of 105 completed trials have results

Key Signals

3 recruiting60 with results20 terminated

Enrollment Performance

Analytics

Phase 3

47(40.5%)

Phase 2

29(25.0%)

Phase 4

25(21.6%)

Phase 1

11(9.5%)

N/A

4(3.4%)

116Total

Phase 3(47)

Phase 2(29)

Phase 4(25)

Phase 1(11)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (135)

Showing 20 of 135 trials

NCT01733082Recruiting

The Mycophenolate Pregnancy Registry

Role: collaborator

NCT05152173Phase 2Completed

Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis

Role: lead

NCT05777031Phase 4Recruiting

Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease

Role: collaborator

NCT06151197Phase 3Active Not Recruiting

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

Role: lead

NCT06169319Phase 2Completed

A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)

Role: lead

NCT05254457Phase 3Completed

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

Role: lead

NCT04456296Phase 4Completed

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Role: lead

NCT05419505Phase 2Completed

Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks

Role: lead

NCT04786106Phase 4Active Not Recruiting

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

Role: collaborator

NCT06649539Phase 4Recruiting

Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease

Role: collaborator

NCT05873595Terminated

Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease

Role: lead

NCT05877066Terminated

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Role: lead

NCT03518034Phase 4Completed

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

Role: collaborator

NCT01013025Completed

Vantas Implant Retrieval Study

Role: lead

NCT00904540Phase 4Completed

Topical Lidocaine Patch in Low Back Pain

Role: lead

NCT01035983Phase 3Completed

Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches

Role: lead

NCT00225797Phase 3Completed

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

Role: lead

NCT00226421Phase 3Completed

Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain

Role: lead

NCT00475514Phase 3Completed

A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine

Role: lead

NCT00226395Phase 3Completed

Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain

Role: lead